What is it about?
A review of the major trials that studied the use of Tocilizumab in the treatment of COVID-19. We highlight the strengths and limitations of each trial and the conclusions drawn from the evidence.
Photo by Martin Sanchez on Unsplash
Why is it important?
The results obtained by a study is only as significant as the quality of the study. It is very important to be able to critically appraise a study before relying on its conclusions.
Read the Original
This page is a summary of: Efficacy of tocilizumab in COVID-19: A review of the current evidence, Science Progress, July 2021, SAGE Publications, DOI: 10.1177/00368504211030372.
You can read the full text:
The following have contributed to this page